Midterm results of Manouguian double valve replacement: Comparison with standard double valve replacement  by Okuyama, Hiroshi et al.
Okuyama et al Surgery for Acquired Cardiovascular DiseaseMidterm results of Manouguian double valve replacement:
Comparison with standard double valve replacement
Hiroshi Okuyama, MDa
Kazuhiro Hashimoto, MDa
Hiromi Kurosawa, MDb
Kei Tanaka, MDa
Yoshimasa Sakamoto, MDaKazuaki Shiratori, MDa
A
CDFrom the Department of Cardiovascular
Surgery,a Jikei University School of Medi-
cine, and the Heart Institute,b Tokyo Wom-
en’s Medical University, Tokyo, Japan.
Received for publication Sept 23, 2004;
revisions received Oct 18, 2004; accepted
for publication Oct 28, 2004.
Address for reprints: Kazuhiro Hashimoto,
MD, Department of Cardiovascular Sur-
gery, Jikei University School of Medicine,
3-25-8, Nishishinbashi, Minatoku, Tokyo,
Japan 105-8461 (E-mail: kaz-hashi@jikei.
ac.jp).
J Thorac Cardiovasc Surg 2005;129:869-74
0022-5223/$30.00
Copyright © 2005 by The American Asso-
ciation for Thoracic Surgery
Okuyama, Hashimoto, Sakamoto (left to right)doi:10.1016/j.jtcvs.2004.10.026Objective: Surgical strategies for patients who have a small aortic annulus associ-
ated with a small mitral annulus remain controversial. The objective of this study
was to assess the validity of the Manouguian procedure for double valve replace-
ment with patch enlargement of the annuli.
Methods: We reviewed 57 consecutive patients who underwent double valve re-
placement for combined aortic and mitral disease between September 1991 and
October 2000. Thirty patients underwent the Manouguian procedure with patch
enlargement of the aortic and mitral annuli, and the other 27 patients had standard
double valve replacement. The Manouguian procedure was selected for a small
aortic annulus of less than 21 mm in diameter. The patients were followed for a
median of 7.5 years. Results of echocardiography and the dobutamine stress test
were compared postoperatively.
Results: Double valve replacement with the Manouguian procedure did not increase
the early or midterm mortality because the survival (including operative death) at 8
years was 83% in the Manouguian group and 84% in the double valve replacement
group (P  .82). The event-free rate at 8 years was 79% in the Manouguian group
and 84% in the double valve replacement group (P  .6). The prostheses implanted
at the aortic and mitral positions were smaller in the Manouguian group, even after
annular enlargement. However, the transprosthetic gradient across the aortic valve
evaluated by means of dobutamine stress echocardiography did not differ between
the 2 groups, possibly because of a smaller body surface area in the Manouguian
group.
Conclusions: The Manouguian patch enlargement procedure is useful during double
valve replacement when associated with the problem of small-valve annuli.
Double valve replacement (DVR), replacement of both the aorticand mitral valves, has been accomplished easily and safely inrecent years. However, combined valvular disease is usually ofrheumatic origin in Japan and is often associated with the problemof small-valve annuli, particularly the aortic annulus. When mitralvalve disease is also associated with a small mitral annulus,
patients might experience prosthesis mismatch after ordinary DVR, leading to
persistent or progressive left ventricular dysfunction. At our hospital, we have
performed enlargement of both the aortic and mitral annuli with a patch to accept a
larger valve prosthesis using the Manouguian (DVR) procedure.1 In recent years,
high-performance prosthetic valves have been introduced,2-4 and this development
might eliminate the need for aggressive enlargement of the valve orifice. However,
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CDsome patients might still require the Manouguian procedure,
despite newer prostheses. Since the Manouguian technique
(DVR) was introduced, only a few case reports about it have
been published,5-8 and no follow-up data are available,
Figure 1. Manouguian annular enlargement.
TABLE 1. Preoperative (original) disease
Aortic valve
AS ASR AR
Manouguian (n  30) 15 8 7
Standard DVR (n  27) 2 11 14
Manouguian vs DVR: P  .01
AS, Aortic stenosis; ASR, aortic stenosis and regurgitation; AR, aortic reg
and regurgitation; MR, mitral regurgitation; DVR, double valve replacemen
TABLE 2. Preoperative patient characteristics
Manouguian (30)
Male/female 10/20
Age (median/min-max), y 56/37-72
BSA (median/min-max), cm2 1.48/1.14-1.88
Previous operations (%) 57
PTMC (n) 1
CMC (n) 3
OMC (n) 10
AVR (n) 1
MVR (n) 2
DVR (n) 0
Atrial fibrillation 23
DVR, Double valve replacement; min-max, minimum-maximum; NS, not s
commissurotomy; CMC, closed mitral commissurotomy; OMC, open mitral cexcept one report on a small number of patients.9
870 The Journal of Thoracic and Cardiovascular Surgery ● ApriIn this study we investigated the early and midterm
results of Manouguian DVR and made a retrospective com-
parison with standard DVR. The pressure gradient across
the aortic valve prosthesis was also assessed by means of
echocardiography. On the basis of our findings, we assessed
the validity of this technique.
Patients and Methods
Patient records and the clinical database were reviewed retrospec-
tively for all 57 consecutive patients who underwent replacement
of the aortic and mitral valves between September 1991 and
October 2000. Thirty patients underwent DVR with Manouguian
annulus enlargement (Manouguian group), and the other 27 pa-
tients underwent standard DVR (DVR group). A St Jude Medical
mechanical prosthesis (Standard; St Jude Medical, Inc, St Paul,
Minn) was used in the aortic position, and a Carbomedics mechan-
ical prosthesis (Sulzer Carbomedics, Inc, Austin, Tex) was used in
the mitral position for all patients because this was our policy at
that time. All valves were placed in the intra-annular position. The
Manouguian procedure was selected for a small aortic valve orifice
of less than 21 mm in diameter on direct measurement with valve
sizers, except in patients with infective endocarditis. The cause of
valve disease was rheumatic in all but 2 patients with infective
endocarditis, and the details are listed in Tables 1 and 2.
The midterm survival and freedom from events (death [includ-
ing operative death], reoperation, cardiac events, and thromboem-
bolic episodes) were reviewed in both groups. Transthoracic echo-
cardiography was carried out at 1 to 3 months after surgical
Mitral valve
IE MS MSR MR IE
AR (1) 17 6 7 MR (1)
AR (1) 7 10 9 1
Manouguian vs DVR: P  .08
tion; IE, infectious endocarditis; MS, mitral stenosis; MSR, mitral stenosis
Standard DVR (27) P value
17,10 .05
55/33-72 NS
1.54/1.07-2.06 NS
22 .05
1
0
3
1
0
1
16 NS
cant; BSA, body surface area; PTMC, percutaneous transluminal mitral
ssurotomy; AVR, aortic valve replacement; MVR, mitral valve replacement.urgitaignifiintervention in all patients, and the prosthetic valve pressure gra-
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diography in 20 volunteers (not intentionally selected) from each
group. Doppler echocardiography was performed at our institute
by the same group of echocardiographers who were unaware of the
operations performed on the patients. Flow velocity in the left
ventricular outflow tract and across the valve was measured by
means of pulsed and continuous wave Doppler ultrasonography,
respectively. Then the modified Bernoulli equation was used to
calculate the mean pressure gradient across the prosthesis. For
dobutamine stress echocardiography, baseline data were obtained
first. Then dobutamine was infused through a peripheral vein at
incremental doses of 3, 6, and 9 g · kg1 · min1 at 10-minute
intervals, and the transaortic prosthetic mean pressure gradient was
measured with each dose of dobutamine. Doppler measurements
were obtained and averaged over 5 representative beats.
Operative Procedure and Anticoagulation
General anesthesia was induced and maintained with fentanyl
citrate and an inhalant (isoflurane or enflurane). Muscle relaxation
was achieved with pancuronium bromide. Cardiopulmonary by-
pass was established by means of direct cannulation of the vena
cava and the aorta. Body temperature was allowed to drift spon-
taneously without active cooling. Cold blood cardioplegia was
used in both the antegrade and retrograde directions according to
the integrated myocardial protection method introduced by Buck-
berg.10 A terminal hot shot was also used. DVR was performed in
the standard fashion, and the Manouguian procedure was based on
the original method,1 with some technical amendments according
to our previous report.11 Briefly, about three quarters of the cir-
cumference of the mitral prosthesis was fixed to the native mitral
ring with 2-0 polyester mattress sutures. Next an equine pericardial
patch shaped like the hull of a ship and lined with a Dacron fabric
patch (about 3  6 cm) was stitched to the remainder of the mitral
valve ring and the prosthesis. The part used for aortic annulus
enlargement (40 mm) was larger than that used for the mitral ring
(25 mm), and a distance of 1 cm was kept between them, which is
TABLE 3. Intraoperative data
Ma
Median aortic diameter (median/min-max), mm
GOAI of AVP (median/min-max), cm2/m2 1
Ao clamp time (median/min-max), min 1
DVR, Double valve replacement; min-max, minimum-maximum; GOAI, geo
aortic.
TABLE 4. Size of prostheses used in aortic and mitral pos
Aortic position
21 mm 23 mm 2
Manouguian (n  30) 1 26
Standard DVR (n  27) 4 12
Manouguian vs DVR: P  .01
DVR, Double valve replacement.equivalent to the size of the aortic-mitral (AM) continuity. Stitch
The Journal of Thoracino. 1 was placed for closure of the left atrium. Stitch no. 2 was a
transitional stitch for approximating the left atrium, the AM con-
tinuity, and the prosthetic valve. Stitch no. 3 was used to recon-
struct the AM continuity and the aorta with the patch. By means of
suturing like this, the patch could be fitted precisely (Figure 1).
Patch closure of the left atrial superior wall was then done with a
running 4-0 polypropylene suture. Next one quarter of the residual
mitral valve cuff was secured to the patch with 2-0 polyester
mattress sutures. A running suture was inserted along the aortic
side of the patch with 4-0 polypropylene sutures from the AM
continuity to the aortic wall. The aortic valve prosthesis was fixed
to the aortic annulus, and the aortic part of the patch was fixed with
2-0 polyester mattress sutures. After trimming the patch, the aortic
wall was finally closed with continuous double running 4-0
Figure 2. Survival curve of the Manouguian group and standard
DVR group.
uian (30) Standard DVR (27) P value
-23 24/23-25 .05
58-2.28 1.82/1.5-2.43 NS
6-290 122/89-177 .05
orifice area index; AVP, aortic valve prosthesis; NS, not significant; Ao,
Mitral position
27 mm 29 mm 31 mm 33 mm
2 19 9 0
4 8 14 1
Manouguian vs DVR: P  .06noug
20/17
.79/1.
89/13
metricition
5 mm
3
11polypropylene sutures.
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mg/d aspirin or 200 mg/d tichropidine) postoperatively. The pro-
thrombin time was maintained at a target international normalized
ratio of 2.1 to 2.5.
Statistical Analysis
Statistical analysis was done with the SAS program (SAS Institute,
Inc, Cary, NC) on a Windows computer. Values are given as the
median and range. Patient characteristics and hospital outcomes were
compared by using the unpaired t test for continuous variables and the
2 test or the Fisher exact test for categorical variables. Continuous
variables at the dobutamine stress test were analyzed by repeated-
measures analysis of variance with the Fisher post-hoc test. Late
survival and freedom from events were evaluated by the Kaplan-
Meier method. Statistical significance of differences in the Kaplan-
Meier curves was determined by the log-rank test.
Results
Stenotic lesions in the aortic position were much more com-
mon in the Manouguian group (Table 1), and the number of
patients with previous operations or female patients was also
significantly greater in the Manouguian group (Table 2). The
age and presence of atrial fibrillation did not differ between the
groups. However, the body surface area of the Manouguian
group was somewhat smaller, although the difference was not
significant (Table 2). The median follow-up period was 7.5
years, ranging from 1 day to 4423 days.
The intraoperative aortic annular diameter of the Man-
ouguian group was significantly smaller than that of the
DVR group, but the geometric orifice area divided by the
body surface area of the aortic valve was not different. The
aortic crossclamp time of the Manouguian group was about
Figure 3. Freedom from events in the M60 minutes longer than that of the standard DVR group
872 The Journal of Thoracic and Cardiovascular Surgery ● Apri(Table 3). The prostheses implanted at the aortic and mitral
positions were smaller in the Manouguian group (Table 4),
but only 1 patient undergoing the Manouguian procedure
received a 21-mm aortic valve. Operative death (death
within 30 days or hospital death after the operation) oc-
curred in 2 (6.7%) patients from the Manouguian group and
2 (7.4%) patients from the standard DVR group. There was
no statistical difference in the early mortality rate. Severe
early complications, such as the need for reopening of the
chest to control bleeding, perivalvular leakage, or hemoly-
sis, were not observed in either group.
The 8-year survival (including operative deaths) was
83% in the Manouguian group and 84% in the standard
DVR group (Figure 2). Three patients from the Manouguian
group died during midterm follow-up because of the recur-
rence of infectious endocarditis (n  1) or thromboembo-
lism (n  2). Two patients from the standard DVR group
died of sudden death (n  1) or thromboembolism (n  1).
The event-free rate was 79% in the Manouguian group and
84% in the standard DVR group after a median follow-up
period of 8 years (P  .6, Figure 3). The international
normalized ratio was optimal in the patients at that time. In
the follow-up period, reoperation was done in 1 patient in
the Manouguian group but no patients in the standard DVR
group. The one patient who required reoperation in the
Manouguian group underwent a modified Bentall procedure
for a mycotic aneurysm of the aortic annulus. He finally
died 6 months after a third operation. There was no signif-
icant difference between the 2 groups with respect to sur-
uguian group and standard DVR group.vival, event-free survival, and reoperation.
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no significant difference of the transprosthetic mean pressure
gradient at the aortic valve between the 2 groups (Figure 4).
Discussion
Surgical management of patients with a small aortic annulus
remains controversial. Several studies have demonstrated
that placing a standard prosthetic aortic valve in a small
aortic annulus without performing enlargement leads to at
least mild stenosis.12-16 High-performance prosthetic valves
have been introduced recently to overcome this problem.2-4
However, a question still remains about whether such ad-
vanced prosthetic aortic valves can avoid significant ob-
struction. The difficulty of placing a valve in a small aortic
annulus becomes much more acute when there is associated
mitral valve disease, particularly mitral stenosis. Insertion
of a properly matched prosthetic valve at the mitral position
first tends to complicate subsequent insertion of the aortic
prosthesis in the narrowed aortic annulus. Thus, a small
mitral valve prosthesis is usually selected to minimize the
difficulty of aortic valve insertion. Patch enlargement of
both the aortic and mitral annuli during DVR is an attractive
and useful procedure to solve this problem. In 1979, Man-
ouguian17 originally reported a technique for aortic valve
replacement with enlargement of a small aortic annulus by
extending the aortic incision to the anterior mitral leaflet.
Patch enlargement of the aortic and mitral annuli with DVR
was experimentally introduced at the same time.1 The aortic
annulus can be enlarged almost as much as needed for the
patient (usually an aortic prosthesis that is 2 sizes larger) by
this technique, and a properly matched mitral valve pros-
thesis can be inserted at the same time. Although a few
reports on DVR with this method have been published, most
Figure 4. Transprosthetic pressure gradients examined
significant difference in the transprosthetic mean presof these are only case reports,5-8 and there is only one
The Journal of Thoracicontaining data on the early and midterm outcome.9 The
purpose of the present study was to clarify any technical
problems and to assess the late outcome in patients treated
at a single institution. We also compared the results with the
outcome of standard DVR (aortic and mitral valves) per-
formed during the same period.
Initially, we were concerned that the Manouguian pro-
cedure might cause some serious postoperative problems
(valve movement, bleeding, hemolysis, leakage, infective
endocarditis, or cardiac failure). However, our experience
demonstrated a similar operative mortality and morbidity as
standard DVR, although the mean aortic crossclamp time
was about 1 hour longer in the Manouguian group. Because
we noted sticking of the valves during surgical intervention
when both valves were placed in a perpendicular direction,
the aortic and mitral prostheses were always oriented in
parallel to prevent interference with each other. According
to Manouguian’s experiment, if the AM continuity is en-
larged by more than 30 mm (a 30-mm increase of the mitral
ring), the ring of mitral prosthesis protrudes into the left
ventricular outflow tract and obstructs it. Thus, after making
Manouguian’s incision and resection of the native valves, it
is important to determine the patch size that is appropriate
for enlargement by inserting a valve sizer. In our series the
expansion of the mitral annulus was usually around 15 to 20
mm. Also, it is important to keep some distance between the
mitral and aortic valve suture lines on the patch.
In addition, we took great care with suturing and approxi-
mation at the transitional areas, such as the mitral ring, the
mitral prosthetic valve cuff, the patch, the left atrial wall, and
the AM continuity. This is a major concern during reconstruc-
tion because these are potential sites of leakage and hemolysis.
Ensuring an appropriate width compatible with the AM con-
h dobutamine stress echocardiography. There was no
gradient at the aortic valve between the 2 groups.wittinuity is also important to prevent such problems. By paying
c and Cardiovascular Surgery ● Volume 129, Number 4 873
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and perivalvular leakage, which were encountered in the series
of Kawachi and associates.9
In Kawachi and associate’s experience,9 5 of 8 patients
needed reoperation. Three cases were caused by structural
failure of Hancock bioprostheses, but prosthetic valve en-
docarditis and leakage occurred in one case each. They
recommended that bioprostheses should not be used and
that mechanical valves were a better choice. This technique
could also be applied to reconstruction after debridement of
infection or abscesses extending to the intervalvular fibrous
trigone in patients with severe acute infective endocarditis.
However, this procedure is associated with a significant risk
of recurrence of endocarditis, and it should be used in those
cases as carefully as possible.
The midterm survival of our patients who had patch en-
largement of the aortic and mitral annuli was similar to that of
our patients who received standard DVR. The midterm mor-
bidity (reoperation, thromboembolic episodes, prosthetic endo-
carditis, and other cardiac events) of the Manouguian group
was also similar to that of the standard DVR group. Although
this series was not a comparative study in patients with small
aortic annuli because whether we used Manouguian DVR
depended on the size of the aortic annulus, echocardiographic
data (pressure gradients across the aortic valve) were similar to
those in the DVR group, suggesting that we could avoid
patient-prosthesis mismatch. Although the aortic prostheses
implanted in the Manouguian group were smaller than those
implanted in the standard DVR group, the body surface area
was also smaller. As a result, dobutamine stress echocardiog-
raphy confirmed the appropriateness of our method by dem-
onstrating the same increase of the pressure gradient in the 2
groups.
We conclude that DVR with the Manouguian procedure
does not lead to increased early or midterm mortality. Mor-
bidity was also comparable with that after standard DVR.
Therefore, we think that the Manouguian procedure is an
appropriate option to improve patient-prosthesis mismatch,
not only for the aortic valve but also for the mitral valve.
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